WallStSmart

Kenvue Inc. (KVUE)vsMagnera Corp placeholder (MAGN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kenvue Inc. generates 368% more annual revenue ($15.29B vs $3.27B). KVUE leads profitability with a 10.6% profit margin vs -3.4%. KVUE appears more attractively valued with a PEG of 1.42. KVUE earns a higher WallStSmart Score of 68/100 (B-).

KVUE

Strong Buy

68

out of 100

Grade: B-

Growth: 6.0Profit: 7.0Value: 4.7Quality: 4.5
Piotroski: 4/9Altman Z: 1.22

MAGN

Hold

41

out of 100

Grade: D

Growth: 5.3Profit: 3.0Value: 4.0Quality: 5.5
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KVUESignificantly Overvalued (-87.1%)

Margin of Safety

-87.1%

Fair Value

$9.91

Current Price

$17.71

$7.80 premium

UndervaluedFair: $9.91Overvalued

Intrinsic value data unavailable for MAGN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KVUE2 strengths · Avg: 8.0/10
Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

EPS GrowthGrowth
46.9%8/10

Earnings expanding 46.9% YoY

MAGN1 strengths · Avg: 10.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Areas to Watch

KVUE2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
4.5%4/10

4.5% revenue growth

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

MAGN4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$399.43M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
4.2%3/10

Operating margin of 4.2%

Debt/EquityHealth
1.893/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : KVUE

The strongest argument for KVUE centers on Operating Margin, EPS Growth. PEG of 1.42 suggests the stock is reasonably priced for its growth.

Bull Case : MAGN

The strongest argument for MAGN centers on Price/Book.

Bear Case : KVUE

The primary concerns for KVUE are Revenue Growth, Altman Z-Score.

Bear Case : MAGN

The primary concerns for MAGN are EPS Growth, Market Cap, Operating Margin. Debt-to-equity of 1.89 is elevated, increasing financial risk.

Key Dynamics to Monitor

KVUE profiles as a value stock while MAGN is a turnaround play — different risk/reward profiles.

KVUE is growing revenue faster at 4.5% — sustainability is the question.

KVUE generates stronger free cash flow (350M), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KVUE scores higher overall (68/100 vs 41/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kenvue Inc.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kenvue Inc. is a consumer health company globally.

Visit Website →

Magnera Corp placeholder

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Magnera Corp (MAGN) is a leading technology firm dedicated to pioneering advanced data analytics and machine learning solutions, playing a vital role in the digital transformation of various sectors. The company's strategic emphasis on operational efficiency is backed by a diverse portfolio of proprietary technologies, reflecting its strong commitment to research and development. Magnera Corp's innovative approach and adaptability not only position it favorably within the technology landscape, but also present an attractive investment opportunity for institutional investors aiming to capitalize on transformative growth trends.

Want to dig deeper into these stocks?